EPO Patent EP4709255A1: Implantable Device for GERD Treatment
Summary
The European Patent Office has published patent application EP4709255A1 for an implantable device and method for treating Gastroesophageal Reflux Disease (GERD). The patent was applied for by Gerdcare Medical Ltd. and lists David Hanuka, Mordechay Esh, Giora Arbel, and Meir Or as inventors.
What changed
The European Patent Office (EPO) has published patent application EP4709255A1, detailing an implantable device and method for treating GERD. This publication signifies the addition of a new patent to the EPO's bulletin, specifically within the A61B classification for diagnostic and surgical instruments.
This patent publication is primarily an informational notice regarding intellectual property. It does not impose new regulatory obligations or compliance requirements on medical device manufacturers or healthcare providers. Regulated entities should note this as a development in medical device technology and intellectual property within the European Union.
Source document (simplified)
IMPLANTABLE DEVICE AND METHOD FOR TREATING GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) AND THE DIGESTIVE SYSTEM
Publication EP4709255A1 Kind: A1 Mar 18, 2026
Applicants
Gerdcare Medical Ltd.
Inventors
HANUKA, David, ESH, Mordechay, ARBEL, Giora, OR, Meir
IPC Classifications
A61B 1/313 20060101AFI20241115BHEP A61N 1/00 20060101ALI20241115BHEP A61B 34/20 20160101ALI20241115BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Diagnosis & Surgery (A61B) publishes new changes.